Omnipod 5 launches in the USA (August 2022)

Insulet Omnipod

As reported in August 2022 by MedTechDive,The Omnipod 5 is one of two insulin pumps manufactured by the company that can be purchased through pharmacies, which Insulet said removes the high-upfront cost and four-year lock-in period associated with sales through durable medical equipment sellers. In a June investor event, the company’s leaders said that they expect the new device will increase the number of new clients won away from competitors. Currently, about 20% of sales come from users who switch from competing devices.

Insulet will report its second quarter earnings results on Thursday afternoon. Analysts are watching for more information on the integration of the Omnipod 5 with Abbott Laboratories’ and Dexcom’s newest CGMs, as well as clearance in Europe and a clinical trial of the device in patients with Type 2 diabetes.

To read more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags